Dermatology · Pasadena, TX
NPI
1851392039
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4419 Crenshaw Rd
Pasadena, TX, 77504
Phone (281) 991-5944
Groups this clinician bills Medicare through
Medicare paid, 2024
$642K
13,104 services
Medicare patients, 2024
1,267
Average age 75
Drug cost, 2024
$219K
2,957 prescriptions
Company payments, 2025
$4,876
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashkan J Ghorbani was code 17003 (destruction skin lesion), 5,950 times for 741 patients. In total Ashkan J Ghorbani billed 13,104 services in 67 codes, and Medicare paid $642K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 5,950 | 741 | $4.89 | $29K |
| 17110 Destruction Skin Lesion | Office | 1,234 | 858 | $84.52 | $104K |
| 17000 Destruction Skin Lesion | Office | 1,047 | 813 | $32.80 | $34K |
| 99214 Office E&M - Established | Office | 1,038 | 669 | $99.90 | $104K |
| 17004 Destruction Skin Lesion | Office | 938 | 506 | $119.93 | $112K |
| 99213 Office E&M - Established | Office | 898 | 563 | $73.72 | $66K |
| 11102 Skin Biopsy | Office | 504 | 405 | $52.23 | $26K |
| 17111 Destruction Skin Lesion | Office | 208 | 178 | $99.29 | $21K |
| 11103 Skin Biopsy | Office | 110 | 86 | $42.38 | $4,662 |
| 99203 Office E&M - New | Office | 99 | 99 | $82.50 | $8,168 |
| 10060 Skin | Office | 77 | 77 | $98.32 | $7,571 |
| 99204 Office E&M - New | Office | 74 | 74 | $120.62 | $8,926 |
| 13132 Wound Repair - All Levels | Office | 73 | 67 | $389.84 | $28K |
| 11643 Skin Lesion Excision | Office | 65 | 61 | $135.54 | $8,810 |
| 13121 Wound Repair - All Levels | Office | 47 | 41 | $352.77 | $17K |
By year: 2022 $651K for 13,092 services; 2023 $590K for 12,513 services; 2024 $642K for 13,104 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| Q0112 All potassium hydroxide (koh) preparations | 23 | 23 | $5.71 | $131 |
Medicare prescription drug claims, 2024
In 2024, the drug Ashkan J Ghorbani prescribed most often to Medicare patients was Metronidazole, with 663 prescriptions and refills. In total Ashkan J Ghorbani wrote 2,957 Medicare prescriptions that cost $219K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metronidazole Generic | 663 | 715 | 397 | $41K |
| Hydrocortisone Generic | 466 | 475 | 360 | $4,039 |
| Ciclopirox Ciclopirox Olamine | 418 | 430 | 218 | $8,092 |
| Triamcinolone Acetonide Generic | 229 | 234 | 188 | $1,571 |
| Mupirocin Generic | 118 | 120 | 75 | $731 |
| Clobetasol Propionate Generic | 113 | 116 | 83 | $3,761 |
| Fluocinonide Generic | 93 | 95 | 71 | $2,935 |
| Terbinafine Hcl Generic | 77 | 78 | 35 | $525 |
| Cephalexin Generic | 72 | 72 | 57 | $103 |
| Fluorouracil Generic | 71 | 72 | 68 | $4,069 |
| Doxycycline Monohydrate Generic | 69 | 74 | 43 | $1,717 |
| Clindamycin Phosphate Generic | 68 | 74 | 37 | $2,146 |
| Valacyclovir Valacyclovir Hcl | 57 | 77 | 26 | $490 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 54 | 54 | 45 | $679 |
| Doxycycline Hyclate Generic | 40 | 40 | 22 | $593 |
Brand drugs: 81 claims; generic drugs: 2,876 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashkan J Ghorbani $4,876 ($4,876 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $601.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 42 | $601 |
| Arcutis Biotherapeutics, Inc. ARQT | 35 | $585 |
| Janssen Biotech, Inc. JNJ | 31 | $527 |
| Novartis Pharmaceuticals Corporation NVS | 23 | $477 |
| LEO Pharma Inc. | 27 | $456 |
| Genzyme Corporation SNY | 14 | $389 |
| Regeneron Healthcare Solutions, Inc. REGN | 14 | $314 |
| UCB, Inc. UCB.BR | 11 | $268 |
| Lilly USA, LLC LLY | 14 | $246 |
| Incyte Corporation INCY | 16 | $228 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.